Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fulcrum Therapeutics Inc (FULC)

Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fulcrum Therapeutics Inc 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 USA

www.fulcrumtx.com Employees: 55 P: 617-651-8851

Sector:

Medical

Description:

Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.

Key Statistics

Overview:

Market Capitalization, $K 460,872
Enterprise Value, $K 263,342
Shares Outstanding, K 66,600
Float, K 61,938
% Float 93.00%
Short Interest, K 4,211
Short Float 6.32%
Days to Cover 3.81
Short Volume Ratio 0.62
% of Insider Shareholders 7.00%
% of Institutional Shareholders 89.83%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -74,880 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -20,330 K
EBIT, $ -84,770 K
EBITDA, $ -83,380 K

Growth:

1-Year Return 137.04%
3-Year Return 123.49%
5-Year Return -37.70%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 57.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 02/24/26
Next Earnings Date 05/07/26
Earnings Per Share ttm -1.18
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

FULC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -30.25%
Return-on-Assets % -28.45%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.15
Book Value/Share 6.45
Interest Coverage -1.61
60-Month Beta 3.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar